Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 4
1946 4
1947 5
1948 3
1949 1
1950 5
1951 6
1952 7
1953 9
1954 6
1955 6
1956 4
1957 6
1958 7
1959 1
1960 2
1961 3
1962 6
1963 8
1964 3
1965 4
1967 1
1968 1
1970 3
1971 5
1972 1
1973 1
1982 1
1984 2
1985 2
1986 2
1987 2
1988 2
1989 4
1990 2
1991 11
1992 21
1993 24
1994 6
1995 4
1996 3
1997 4
1998 1
1999 3
2000 1
2001 1
2002 1
2003 2
2004 1
2005 1
2007 1
2008 2
2009 2
2010 7
2011 2
2012 4
2013 7
2014 3
2015 8
2016 6
2017 16
2018 16
2019 20
2020 21
2021 21
2022 15
2023 13
2024 14
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.
Labidi-Galy SI, Rodrigues M, Sandoval JL, Kurtz JE, Heitz F, Mosconi AM, Romero I, Denison U, Nagao S, Vergote I, Parma G, Nøttrup TJ, Rouleau E, Garnier G, El-Balat A, Zamagni C, Martín-Lorente C, Pujade-Lauraine E, Fiévet A, Ray-Coquard IL. Labidi-Galy SI, et al. Among authors: garnier g. Ann Oncol. 2023 Feb;34(2):152-162. doi: 10.1016/j.annonc.2022.11.003. Epub 2022 Nov 28. Ann Oncol. 2023. PMID: 36564284 Free article.
Fibrinogen Diagnostics in Major Hemorrhage.
Bialkower M, Garnier G. Bialkower M, et al. Among authors: garnier g. Crit Rev Anal Chem. 2022;52(1):194-209. doi: 10.1080/10408347.2020.1793098. Epub 2020 Jul 20. Crit Rev Anal Chem. 2022. PMID: 32683907 Review.
Engineering nanocellulose hydrogels for biomedical applications.
Curvello R, Raghuwanshi VS, Garnier G. Curvello R, et al. Among authors: garnier g. Adv Colloid Interface Sci. 2019 May;267:47-61. doi: 10.1016/j.cis.2019.03.002. Epub 2019 Mar 8. Adv Colloid Interface Sci. 2019. PMID: 30884359 Review.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2025 Feb;36(2):185-196. doi: 10.1016/j.annonc.2024.10.828. Epub 2024 Nov 9. Ann Oncol. 2025. PMID: 39528049 Free article. Clinical Trial.
Management of acute radiation syndrome.
Arnautou P, Garnier G, Maillot J, Konopacki J, Brachet M, Bonnin A, Amabile JC, Malfuson JV. Arnautou P, et al. Among authors: garnier g. Transfus Clin Biol. 2024 Nov;31(4):253-259. doi: 10.1016/j.tracli.2024.07.002. Epub 2024 Jul 16. Transfus Clin Biol. 2024. PMID: 39025400 Review.
Cellulose Nano-Films as Bio-Interfaces.
Raghuwanshi VS, Garnier G. Raghuwanshi VS, et al. Among authors: garnier g. Front Chem. 2019 Jul 30;7:535. doi: 10.3389/fchem.2019.00535. eCollection 2019. Front Chem. 2019. PMID: 31417896 Free PMC article. Review.
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
[Dermatology].
GARNIER G. GARNIER G. Gaz Med Fr. 1963 Jun 25;70:2183-90. Gaz Med Fr. 1963. PMID: 14010305 French. No abstract available.
Pattern formation in drying blood drops.
Hertaeg MJ, Tabor RF, Routh AF, Garnier G. Hertaeg MJ, et al. Among authors: garnier g. Philos Trans A Math Phys Eng Sci. 2021 Aug 9;379(2203):20200391. doi: 10.1098/rsta.2020.0391. Epub 2021 Jun 21. Philos Trans A Math Phys Eng Sci. 2021. PMID: 34148412 Free PMC article.
364 results